BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12007728)

  • 1. Incidence of diabetic nephropathy in Type 1 diabetic patients in Spain: 'Estudio Diamante'.
    Esmatjes E; De Alvaro F;
    Diabetes Res Clin Pract; 2002 Jul; 57(1):35-43. PubMed ID: 12007728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal involvement in type 1 (IDDM) diabetes in Spain. ESTUDIO DIAMANTE.
    Diabetes Res Clin Pract; 1997 Nov; 38(2):129-37. PubMed ID: 9483377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.
    Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Pagano G; Cavallo Perin P;
    Diabetes Care; 2003 Jul; 26(7):2150-5. PubMed ID: 12832328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group.
    Diabet Med; 1999 Nov; 16(11):918-25. PubMed ID: 10588521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.
    Park JY; Kim HK; Chung YE; Kim SW; Hong SK; Lee KU
    Diabetes Care; 1998 Apr; 21(4):530-4. PubMed ID: 9571337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study.
    Yokoyama H; Jensen JS; Myrup B; Mathiesen ER; Rønn B; Deckert T
    Diabetes Care; 1996 May; 19(5):435-40. PubMed ID: 8732705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of microalbuminuria in IDDM. A five-year follow-up study.
    Almdal T; Nörgaard K; Feldt-Rasmussen B; Deckert T
    Diabetes Care; 1994 Feb; 17(2):120-5. PubMed ID: 8137681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
    Coonrod BA; Ellis D; Becker DJ; Bunker CH; Kelsey SF; Lloyd CE; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1993 Oct; 16(10):1376-83. PubMed ID: 8269796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.
    Powrie JK; Watts GF; Ingham JN; Taub NA; Talmud PJ; Shaw KM
    BMJ; 1994 Dec; 309(6969):1608-12. PubMed ID: 7819935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 10-year incidence of renal insufficiency in people with type 1 diabetes.
    Klein R; Klein BE; Moss SE; Cruickshanks KJ; Brazy PC
    Diabetes Care; 1999 May; 22(5):743-51. PubMed ID: 10332675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.
    Cederholm J; Eliasson B; Nilsson PM; Weiss L; Gudbjörnsdottir S;
    Diabetes Res Clin Pract; 2005 Mar; 67(3):258-66. PubMed ID: 15713359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.
    Torffvit O; Agardh CD
    J Diabetes Complications; 2001; 15(6):307-13. PubMed ID: 11711324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between diabetic retinopathy, microalbuminuria and overt nephropathy, and twenty-year incidence follow-up of a sample of type 1 diabetic patients.
    Romero-Aroca P; Baget-Bernaldiz M; Reyes-Torres J; Fernandez-Ballart J; Plana-Gil N; Mendez-Marin I; Pareja-Rios A
    J Diabetes Complications; 2012; 26(6):506-12. PubMed ID: 22921286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients.
    Dahlquist G; Stattin EL; Rudberg S
    Nephrol Dial Transplant; 2001 Jul; 16(7):1382-6. PubMed ID: 11427629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study.
    Rosenlund S; Hansen TW; Andersen S; Rossing P
    Diabet Med; 2015 Nov; 32(11):1445-52. PubMed ID: 26331364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.
    Hsu CC; Chang HY; Huang MC; Hwang SJ; Yang YC; Lee YS; Shin SJ; Tai TY
    Diabetologia; 2012 Dec; 55(12):3163-72. PubMed ID: 22923064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is microalbuminuria a risk factor for diabetic retinopathy?].
    Romero Aroca P; Salvat Serra M; Mendez Marin I; Martinez Salcedo I
    J Fr Ophtalmol; 2003 Sep; 26(7):680-4. PubMed ID: 13130255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unchanged incidence of diabetic nephropathy in IDDM patients.
    Rossing P; Rossing K; Jacobsen P; Parving HH
    Diabetes; 1995 Jul; 44(7):739-43. PubMed ID: 7789641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.